UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 1, 2015
CVS HEALTH CORPORATION
(Exact Name of Registrant
as Specified in its Charter)
| Delaware | ||||
| (State or Other Jurisdiction of Incorporation) | ||||
| 001-01011 | 05-0494040 | |||
| (Commission File Number) | (IRS Employer Identification No.) | |||
| One CVS Drive | ||
| Woonsocket, Rhode Island | 02895 | |
| (Address of Principal Executive Offices) | (Zip Code) | |
Registrant’s telephone number, including area code: (401) 765-1500 |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 Results of Operations and Financial Condition.
On May 1, 2015, CVS Health Corporation (the “Company”) issued a press release announcing its earnings for the three months ended March 31, 2015. Attached to this Current Report on Form 8-K as Exhibit 99.1, is a copy of the Company’s related press release dated May 1, 2015.
The information in this report is being furnished, not filed. Accordingly, the information in Item 9.01 of this report will not be incorporated by reference into any registration statement filed by the Company under the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
99.1 Press Release, dated May 1, 2015, of CVS Health Corporation.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| CVS HEALTH CORPORATION | |||
| By: | /s/ David M. Denton | ||
| David M. Denton | |||
| Executive Vice President and | |||
| Chief Financial Officer | |||
| Dated: | May 1, 2015 | ||